Clinical Trial Update: Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

Phase 3 safety evaluation of Technosphere insulin in adults with Type 1 or Type 2 diabetes who also have moderate COPD or asthma; the study was terminated and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2016-02-15